Andrew J. Karter, PhD, has been a research scientist at the Division of Research, Kaiser Permanente Northern California (KPNC), since 1994. He received his doctorate in 1993 in epidemiology with a special emphasis on epidemiologic methods and biostatistics, and was awarded Phi Beta Kappa, Summa Cum Laude, and a Fulbright fellowship. Dr. Karter’s current research interests include epidemiology and health services research with a focus on diabetes and its complications, and, more specifically, race/ethnic and socioeconomic health disparities, pharmacotherapy, consequences of cost-sharing, cultural, and linguistic barriers to health care access, medication adherence and diabetes self-management practices, and depression. He conducts ongoing research into medication adherence and the practice of self-monitoring of blood glucose. Dr. Karter has recently initiated research into the pharmaco- epidemiology of diabetes medications with a special emphasis on effectiveness, adverse events, and medication adherence and costs. He is a faculty member of the Robert Wood Johnson Foundation’s Health and Society Scholars Program; an Affiliate Professor, Dept. of Epidemiology, School of Public Health & Community Health, University of Washington; and on the executive committee for the International Working Group on Self-Monitoring of Blood Glucose. Dr. Karter plays a lead role in managing the KPNC Diabetes Registry (n~210,000 patients), overseeing database architecture design, identification of incident cases and database maintenance.
Current Position
Senior Investigator, Division of Research, Kaiser Permanente Northern California
Faculty member of Robert Wood Johnson Foundation’s Health and Society Scholars Program.
Affiliate Professor, Dept. of Epidemiology, School of Public Health & Community Health, University of Washington
Current and Recently Completed Research Projects
Changes in strip utilization for self-monitoring of blood glucose with the distribution of free strips following a policy change (California State Senate Bill 64) (NIDDK; PI)
Educational Disparities in Diabetes Complications (NICHD, Principal Investigator)
Racial Disparities in Diabetes Complications (NIDDK, Principal Investigators)
Long-term use of Thiazolidinediones and Congestive Heart Failure (ADA, Principal Investigator)
TRIAD: Translational Research Centers for Diabetes Control Within Managed Care (CDC & NIDDK; Co-Principal Investigator)
Insulin Resistance and Atherosclerosis Study (NHLBI; Co-Investigator)
Select First-Authored Publications
Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB, Ferrara A, Liu J, Selby JV. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1-9.
Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population: The Northern California Diabetes Registry. JAMA 2002:287:2519-27.
Karter AJ. Commentary: Race, genetics, and disease- in search of a middle ground. Int J Epidemiol 2003;32:26-8.
Karter AJ, Thom DH, Liu J, Moffet HH, Ferrara A, Selby JV. Use of antibiotics is not associated with decreased risk of myocardial infarction among patients with diabetes. Diabetes Care. 2003;26:2100-6.
Karter AJ, Stevens MR, Herman WH, Ettner S, Marrero DG, Safford MM, Engelgau MM, Curb JD, Brown AF. Out-of-Pocket Costs and Diabetes Preventive Services: The Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2003;26:2294-9.
Karter AJ. Race and ethnicity: Vital constructs for diabetes research. Diabetes Care 2003;26:2189-93.
Karter AJ, Parker MM, Moffet HH, Ahmed AT, Ferrara A, Liu JY, Selby JV. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care 2004;42:110-5.
Karter AJ, Ahmed AT, Liu J, Moffett HH, Parker MM, Ferrara A, Selby JV. Association between use of Thiazolidinediones and risk of heart failure: real or artifactual? Response to Delea, et al. Diabetes Care 2004;27.
Karter AJ, D'Agostino RB Jr, Mayer-Davis EJ, Wagenknecht LE, Hanley AJ, Hamman RF, Bergman R, Saad MF, Haffner SM; for the IRAS investigators. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab 2005;7:230-8.
Karter AJ, Moffett HH, Liu J, Parker MM, Ahmed AT, Ferrara A, Selby JV. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. Am J Manag Care 2005;11:262-70.
Karter AJ, Ahmed AT, Liu JY, Moffet H, Parker MM. Pioglitizone and susequent congestive heart failure among patients initiating new diabetes therapies. Diabetic Medicine. 2005;22:986-93.
Karter AJ, Ahmed AT, Liu J, Moffet HH, Parker MM. Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Diabet Med. 2005:986-93.
Karter AJ. The role of blood glucose self-monitoring in glycemic control. Endocrine Practice. 2006;12(Suppl 1):110-17.
Karter AJ, Parker MM, Moffett HH, Spence MM, Chan J, Ettner SL, Selby JV. Longitudinal study of new and ongoing use of self monitoring of blood glucose. Diabetes Care 2006;29:1757-63.
Karter AJ, Moffet HM, Liu, J Parker MM, Ahmed AT, Go AS, Selby JV. Glycemic response to newly initiated diabetes therapies. Am J Manag Care 2007;13:596-606.
Karter AJ, Parker MM, Moffet HM, Chan J, Spence M, Ahmed AT, Selby JV, Ettner S. The impact of cost-sharing policy changes on the practice of self-monitoring of blood glucose. Am J Manag Care 2007;13:408-16.
Karter AJ, Stevens MR, Brown AF, Duru OK, Gregg EW, Gary TL, Beckles GL, Tseng CW, Marrero DG, Waitzfelder B, Herman WH, Piette JD, Safford MM, Ettner SL. Educational disparities in health behaviors among patients with diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study. BMC Public Health 2007;7:308.
Karter AJ, Stevens M, Gregg E, Brown A, Tseng C-W, Marrero D, Duru OK, Gary T, Piette John D, Waitzfelder B, Herman W, Beckles G, Safford M, Ettner S. High rates of smoking among poorly educated young adults with diabetes in the Translating Research Into Action for Diabetes Study. Am J Public Health 2008;98:365-70.
DOR Administrative Offices
2000 Broadway
Oakland, CA 94612
DOR Clinics
3505 Broadway
Oakland, CA 94611
(510) 891 - 3400